Nasdaq:US$17.45 (-0.09) | HKEX:HK$26.92 (-0.76) | AIM:£2.47 (-0.03)
Search Result
Previous Article   |   Next Article
公告及新闻稿, 其他业务 | 17 Apr 2014

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture